LTZ Therapeutics
San Francisco
About LTZ Therapeutics
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $87.0M
- Last round: Corporate Round (Jul 2025)
- Website: ltztherapeutics.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/ltz-therapeutics-2328 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.